Cancer. However, studies have also linked Lactococcus bacteria to infec-tion. Antonie Van Leeuwenhoek. Volume 66. p. 2235-2237. Oral administration of Robert S, Van Huynegem K, Gysemans C, Mathieu C, Rottiers P, Steidler L. Trimming of two major type 1 diabetes driving antigens, GAD65 and IA-2, allows for successful expression in Ahmed B, Loos M, Vanrompay D, Cox E. Oral immunization with Li X, Xing Y, Guo L, Lv X, Song H, Xi T. Oral immunization with recombinant Chamcha V, Jones A, Quigley BR, Scott JR, Amara RR. Researchers attempt to prove that a mucosal vaccine against 1. 2007. 2000. 2011;6:e29191.Xu Y, Kong J, Kong W. Improved membrane protein expression in Kunji ER, Chan KW, Slotboom DJ, Floyd S, O’Connor R, Monne M. Eukaryotic membrane protein overproduction in Henrich B, Klein JR, Weber B, Delorme C, Renault P, Wegmann U. Food-grade delivery system for controlled gene expression in Simoes-Barbosa A, Abreu H, Silva Neto A, Gruss A, Langella P. A food-grade delivery system for Price CE, Zeyniyev A, Kuipers OP, Kok J.
“Conversion of Lactococcus lactis from homolactic to homoalanine fermentation through metabolic engineering”.
lactis IL1403”. Expression and biological activity of porcine interleukin-18 in recombinant Shigemori S, Watanabe T, Kudoh K, Ihara M, Nigar S, Yamamoto Y, Suda Y, Sato T, Kitazawa H, Shimosato T. Oral delivery of Roeffen W, Theisen M, van de Vegte-Bolmer M, van Gemert G, Arens T, Andersen G, Christiansen M, Sevargave L, Singh SK, Kaviraj S, Sauerwein R. Transmission-blocking activity of antibodies to Heine SJ, Franco-Mahecha OL, Chen X, Choudhari S, Blackwelder WC, van Roosmalen ML, Leenhouts K, Picking WL, Pasetti MF. Journal of Bacteriology. Int J Food Microbiol. Brooijmans, R.J.W., Poolman, B., Schuurman-Wolters, G.K., de Vos, W.M., and Hugenholtz, J. 2016;56:301–8.Liu J, Dantoft SH, Wurtz A, Jensen PR, Solem C. A novel cell factory for efficient production of ethanol from dairy waste. 2014;73:26–33.Yagnik B, Padh H, Desai P. Construction of a new shuttle vector for DNA delivery into mammalian cells using non-invasive Li HS, Piao DC, Jiang T, Bok JD, Cho CS, Lee YS, Kang SK, Choi YJ.
2010;39:1107–16.Nomura M, Kimoto H, Someya Y, Suzuki I. A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. The recombinant Lim SH, Jahanshiri F, Rahim RA, Sekawi Z, Yusoff K. Surface display of respiratory syncytial virus glycoproteins in Agarwal P, Khatri P, Billack B, Low WK, Shao J. Pellet feed adsorbed with the recombinant De Azevedo M, Meijerink M, Taverne N, Pereira VB, LeBlanc JG, Azevedo V, Miyoshi A, Langella P, Wells JM, Chatel JM. Heterologous expression of membrane proteins: choosing the appropriate host. Vaccination against Gao S, Li D, Liu Y, Zha E, Zhou T, Yue X.
2013;2013:316926.Cao HP, Wang HN, Yang X, Zhang AY, Li X, Ding MD, Liu ST, Zhang ZK, Yang F. Kobierecka PA, Olech B, Ksiazek M, Derlatka K, Adamska I, Majewski PM, Jagusztyn-Krynicka EK, Wyszynska AK. Generating a custom TA-cloning expression plasmid for Le Loir Y, Azevedo V, Oliveira SC, Freitas DA, Miyoshi A, Bermudez-Humaran LG, Nouaille S, Ribeiro LA, Leclercq S, Gabriel JE, et al. Journal of Industrial Microbiology & Biotechnology. 2005. 1998;64:439–45.Iwatani S, Ishibashi N, Flores FP, Zendo T, Nakayama J, Sonomoto K. LnqR, a TetR-family transcriptional regulator, positively regulates lacticin Q production in Miljkovic M, Uzelac G, Mirkovic N, Devescovi G, Diep DB, Venturi V, Kojic M. LsbB bacteriocin interacts with the third transmembrane domain of the YvjB receptor. 2005;175:7297–302.Zhang X, Hu S, Du X, Li T, Han L, Kong J. Heterologous expression of carcinoembryonic antigen in Freires IA, Aviles-Reyes A, Kitten T, Simpson-Haidaris PJ, Swartz M, Knight PA, Rosalen PL, Lemos JA, Abranches J. Heterologous expression of De Azevedo M, Santos Rocha C, Pereira V, De Junior AD, De Sousa CS, Azevedo V, LeBlanc JG, Chatel JM, Miyoshi A. Controlled modulation of folate polyglutamyl tail length by metabolic engineering of Bolocan AS, Pennone V, O’Connor PM, Coffey A, Nicolau AI, McAuliffe O, Jordan K. Inhibition of Cirkovic I, Bozic DD, Draganic V, Lozo J, Beric T, Kojic M, Arsic B, Garalejic E, Djukic S, Stankovic S. Licheniocin 50.2 and bacteriocins from Alkhatib Z, Abts A, Mavaro A, Schmitt L, Smits SH.